Dermatology - Research

We have recently partnered with Pace Dermatology to bring more accessible and innovative dermatology treatments to patients in the South Sound and Pacific Northwest. Together, patients benefit from the research expertise of the MultiCare’s Institute for Research & Innovation and the highly-skilled, passionate clinical team at Pace Dermatology. 

Dermatology studies include, but are not limited to, the following therapeutic areas:

  • Psoriasis
  • Atopic dermatitis
  • Pediatric trails coming soon

Drs. Aaron and Andrew Pace lead Pace Dermatology – with locations in Tacoma and Lakewood. They are board certified in dermatology, so patients can expect the highest level of care. 

Please click here to learn more about Pace Dermatology.

Dermatology Studies Accepting Participants

Pediatrics - Regeneron Atopic Dermatitis

Study Number: Regeneron R668-AD-1607 - An Open-Label, Randomized, Actual Use Study of Dupilumab Auto-Injector Device in Patients with Atopic Dermatitis.

Study Info

Principal Investigator: Aaron Pace, MD

Study Coordinator: Danielle Wahinekapu, [email protected], 253-301-6992

Adult - Biomarker Study

Study Number: MTG-002 - Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients.

Principal Investigator: Andrew Pace, MD

Study Coordinator: Danielle Wahinekapu, [email protected], 253-301-6992

Adult - Voltaire-X

Study Number: 1297.9 - Pharmacokinetics, safety, immunogenicity and efficacy of BI 695501 versus Humira in patients with moderate to severe chronic plaque psoriasis: a randomized, double-blind, parallel-arm, multiple-dose, active comparator.

Principal Investigator: Aaron Pace, MD

Study Coordinator: Danielle Wahinekapu, [email protected], 253-301-6992